English
Deutsch
What are the benefits of RhinoChill®?
- RhinoChill® overcomes the limitations of other temperature reduction technologies – limitations that prevent early and rapid initiation of patient cooling.
- With RhinoChill®, for the first time in the history of mild therapeutic hypothermia, it is possible to effectively preserve the brain during cerebral ischemia events.1
- Therapeutic hypothermia can be started in the field and continued until the cooled patient is connected to a maintenance cooling device in the ICU.
- RhinoChill® is easy to use, portable, compact, and its transnasal evaporative manner of cooling is recognized in the ERC guidelines as an appropriate means to induce therapeutic hypothermia.2
- – “… Ultimately, starting cooling during cardiac arrest may be most beneficial.” ERC guidelines 2010. RhinoChill® may help lower overall treatment costs3
RhinoChill® is a practical and portable non-invasive solution to induce therapeutic hypothermia in the EMS, ED. Cath lab and ICU.
1. Guan J, et al. Rapid induction of head cooling by the intranasal route during cardiopulmonary resuscitation improves survival and neurological outcomes. Crit Care Med. 2008; 36: [Suppl.]:S428 –S433.
2. Deakin CD, Nolan JP, Soar J, Sunde K, Koster RW, Smith GB, Perkins GD. European Resuscitation Council Guidelines for Resuscitation 2010. Section 4. Adult advanced life support. Resuscitation. 2010;81:1305-1352.
3. Castrén M et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010;122(7):729-736.
